In addition to Kv2.1, the expression levels of GABAα6 (γ-aminobutyric acid α6) receptor and p-CREB (cAMP-response-element-binding protein), two typical markers of CGN development, were also enhanced by GDF15 treatment (results not shown). This evidence concerns the gene CREB1 and childhood gender nonconformity.